Original air date: 6/11/19 
This course has expired and is no longer eligible for CLE.

Inequitable conduct remains a concern for all patent practitioners who have the Duty of Candor, whether they are US practitioners or not. Related patent proceedings co-pending US applications, foreign prosecution, oppositions, litigation, etc. require heightened attention. When can FDA communications cause risk? When can Supplemental Examination be used, when can it not be used, and when might other proceedings be considered?

Join our speakers to learn how to minimize risk and how to counsel your clients if concerns arise.

Presented by: